Opdivo

Active substance

Nivolumab

Holder

Bristol-Myers Squibb NV

Status

Running

Indication

Adult patients with unresectable Malignant Pleural Mesothelioma who have progressed after at least one line of treatment including pemetrexed in combination with platinum agent.

Public documents

Approbation

Information for the patient

Informed consent

Last update

21/05/2019

Last updated on 21/05/2019